Workday HCM Functional Manager at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

Bachelor’s degree in HR, Business, Information Systems, or related field required
Minimum of 5 years of experience in HRIS or HR technology roles, with at least 4+ years of hands-on Workday Core HCM configuration experience
Proven expertise in Core HR, including foundational data, worker structures, positions, job profiles, organizations, and security
Strong track record in Workday release management, testing coordination, and post-deployment validation
Demonstrated ability to manage global stakeholders and balance competing requirements
Advanced proficiency in Workday Core HCM configuration and security

Responsibilities

Own and manage the global Workday Core HR module, including Core Compensation, Onboarding, and Security Administration
Lead configuration, testing, and deployment of updates and new capabilities within the Core HR module
Serve as the functional lead for Workday biannual releases — evaluating new features, managing regression testing, and coordinating deployment of approved functionality
Partner with HR Centers of Excellence (COEs), HR Operations, and IT to gather business requirements and translate them into Workday solutions
Manage the demand intake process for Core HR enhancements, ensuring clear prioritization and alignment with global HR strategy
Oversee security administration in Workday, ensuring proper governance, role-based access, and compliance
Serve as the Security Administrator responsible for creating new roles, maintaining role-based and user-based access, and ensuring security alignment with global policies
Own and manage all business and system controls related to Core HR, ensuring compliance, data integrity, and proper governance across global processes
Maintain system documentation, process maps, and configuration guides to support ongoing operations and audits
Identify opportunities for process optimization and automation using Workday capabilities and best practices
Act as the decision-maker for configuration and design choices within the Core HR module, balancing global consistency with local compliance
Evaluate new Workday functionality and determine adoption recommendations based on business impact and readiness
Prioritize enhancement requests and ensure alignment with HRIS roadmap and governance processes

Skills

Workday HCM

Workday Core HR

Core Compensation

Onboarding

Security Administration

Workday Configuration

Workday Testing

Workday Deployment

Workday Releases

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free